跳至主要内容
临床试验/NCT04640376
NCT04640376已完成3 期

Comparison of the Analgesic Effect of a New Paracetamol Formulation (Paracetamol UNIFLASH) for Buccal Use and Two Different Doses of an Oral Paracetamol Form Controlled Versus Placebo in Patients Suffering From Moderate Pain Due to a Tooth Extraction.

Unither Pharmaceuticals, France20 个研究点 分布在 4 个国家目标入组 407 人开始时间: 2021年3月24日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
407
试验地点
20
主要终点
Ranked Efficacy Endpoints: 1. Sum of Pain Intensity Difference (SPID0-60min)

研究概览

简要总结

This study aims to evaluate the analgesic efficacy of single dose of a new paracetamol formulation (paracetamol UNIFLASH) for buccal use in comparison to two different doses of an oral paracetamol form controlled versus placebo.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

盲法说明

Double-blind. Participants, Investigators, and all persons involved in the conduct, data management, and analysis of the study will be fully blind to the participant's treatment.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male and female patients aged from 18 years of age
  • Patients scheduled to undergo the removal of one third soft-tissue impacted or not-impacted mandibular molar (associated or not to an ipsilateral erupted maxillary molar) under short-acting local anaesthetic preoperatively;
  • Patients weighing > 50 kg;
  • Additional inclusion criteria
  • Patients experiencing a moderate pain within 4 hours after the dental extraction, defined by a baseline pain intensity Visual Analogic Scale (VAS) score ≥ 40 mm and ≤ 60 mm;
  • Third mandibular molar extraction completed without any immediate complication, that in the opinion of the investigator, would interfere with the study conduct and/or assessments (e.g., suspected neurosensory complication, incomplete removal of tooth).

排除标准

  • Patient who undergoes an extraction of contralateral molar in the same procedure or a bony-impacted molar;
  • Patients treated by analgesics or nonsteroidal anti-inflammatory drugs (NSAIDs) within the 3 days prior to the day of randomization (or within 5 times the elimination half-life whichever the longest);
  • Patient who received other analgesic than short-acting preoperative or intraoperative local anaesthetic agents within 12 hours before the start of the surgery or peri-operatively until randomization;
  • Patients with any known hypersensitivity to paracetamol, ibuprofen or ingredients contained in IMPs and Non-Investigational Medicinal Product (NIMP);

研究组 & 干预措施

Paracetamol UNIFLASH 125mg

Experimental

1 sachet Paracetamol UNIFLASH 125mg + 2 placebo capsule

干预措施: Paracetamol Uniflash 125mg (Drug)

Paracetamol UNIFLASH 125mg

Experimental

1 sachet Paracetamol UNIFLASH 125mg + 2 placebo capsule

干预措施: Placebo (Drug)

Placebo

Placebo Comparator

1 Placebo sachet + 2 placebo capsule

干预措施: Placebo (Drug)

Paracetamol 500mg

Active Comparator

1 Placebo sachet + 1 placebo capsule + 1 capsule Panadol 500mg

干预措施: Panadol 500 MG Oral Tablet X1 (Drug)

Paracetamol 500mg

Active Comparator

1 Placebo sachet + 1 placebo capsule + 1 capsule Panadol 500mg

干预措施: Placebo (Drug)

Paracetamol 1000mg

Active Comparator

1 Placebo sachet + 2 capsules Panadol 500mg

干预措施: Panadol 500 MG Oral Tablet X2 (Drug)

Paracetamol 1000mg

Active Comparator

1 Placebo sachet + 2 capsules Panadol 500mg

干预措施: Placebo (Drug)

结局指标

主要结局

Ranked Efficacy Endpoints: 1. Sum of Pain Intensity Difference (SPID0-60min)

时间窗: At 60 minutes

Pain Intensity Difference will be calculated using the scores of pain intensity assessed by the patient at defined time-points (T5, T10, T15, T20, T30, T45, T60 min) after the IMP intake and/or right before first intake of rescue medication using a 100-mm Visual Analogic Scale (0= no pain and 100= worst imaginable pain) compared to baseline

Proportion of responder patients at 60 minutes (versus 500 mg of the reference oral paracetamol (Panadol®)).

时间窗: At 60 minutes

A responder patient is defined as a subject who achieves a reduction of 50 % of pain intensity compared to baseline.

Patient Global Impression of Change (PGIC) versus 1000 mg of the reference oral paracetamol (Panadol®)

时间窗: At 60 minutes

Onset of pain relief (versus 500 mg of the reference oral paracetamol (Panadol®)

时间窗: At 60 minutes

Defined as the period for the patient to reach a meaningful pain relief during the first 60 min post-IMP intake. After completion of the 5-point verbal rating scale (VRS) at T5, T10, T15, T20, T30, T45, T60 min post-IMP intake assessment time points, the patient will have to answer this question "Do you consider this level of pain relief as meaningful - Yes or No?"

Onset of pain relief (versus 1000 mg of the reference oral paracetamol (Panadol®)).

时间窗: At 60 minutes

Defined as the period for the patient to reach a meaningful pain relief during the first 60 min post-IMP intake. After completion of the a 5-point verbal rating scale at T5, T10, T15, T20, T30, T45, T60 min post-IMP intake assessment time points, the patient will have to answer this question "Do you consider this level of pain relief as meaningful - Yes or No?"

次要结局

  • Sum of Pain Intensity Difference at 5 minutes (SPID0-5min), 10 minutes (SPID0-10min), 30 minutes (SPID0-30min), 45 minutes (SPID0-45min), 1 hour (SPID0-1h), 2 hours (SPID0-2h), 4 hours (SPID0-4h), and 6 hours (SPID0-6h).(At 5 minutes, 10 minutes, 30 minutes, 45 minutes, 1 hour, 2 hours, 4 hours, and 6 hours.)
  • Proportion of patients taking a rescue analgesic treatment.(At 6 hours)
  • Proportion of responders at 60 minutes (versus 1000 mg of the reference oral paracetamol (Panadol®)).(At 60 minutes)
  • Proportion of responders at 5 minutes, 10 minutes, 30 minutes, 45 minutes, 2 hours, 4 hours and then 6 hours.(At 5 minutes, 10 minutes, 30 minutes, 45 minutes, 2 hours, 4 hours and then 6 hours.)
  • Patient Global Impression of Change (PGIC) versus 500 mg of the reference oral paracetamol (Panadol®)(At 60 minutes)
  • Total Pain Relief at 1 hour (TOTPAR0-1h), 2 hours (TOTPAR0-2h), 4 hours (TOTPAR0-4h) and 6 hours (TOTPAR0-6h)(At 1 hour, 2 hours, 4 hours and 6 hours.)
  • Period of time before taking rescue analgesic treatment intake.(Up to 24 hours after dose)
  • Patient Global Impression of Change (PGIC) versus 500 mg and 1000 mg of the reference oral paracetamol (Panadol®)(At 360 minutes)

研究者

发起方
Unither Pharmaceuticals, France
申办方类型
Industry
责任方
Sponsor

研究点 (20)

Loading locations...

相似试验